FDA NDC Directory · JSON-LD · Markdown

EYLEA

NDC 61755-005 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameaflibercept
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA125387
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsAFLIBERCEPT (40 mg/mL)
Marketing started20111121
Package count4

External sources

Source: openFDA. Public-domain (CC0).